NEW YORK — Pfizer Inc. today reported fourth-quarter profit of $3.39 billion.

The company said it had profit of 59 cents per share. Earnings, adjusted for research and development costs and non-recurring costs, came to $1.08 per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 85 cents per share.

The drugmaker posted revenue of $23.84 billion in the period.

Pfizer expects full-year earnings in the range of $6.35 to $6.55 per share, with revenue in the range of $98 billion to $102 billion.